vs
Aligos Therapeutics, Inc.(ALGS)与Strive, Inc.(ASST)财务数据对比。点击上方公司名可切换其他公司
Strive, Inc.的季度营收约是Aligos Therapeutics, Inc.的1.5倍($255.0K vs $169.0K),Aligos Therapeutics, Inc.同比增速更快(-72.1% vs -74.1%),过去两年Strive, Inc.的营收复合增速更高(77.6% vs -50.7%)
Aligos Therapeutics是一家临床阶段生物制药企业,专注于开发针对流行性肝病与病毒感染的新型靶向疗法,核心管线覆盖慢性乙型肝炎、非酒精性脂肪性肝炎等适应症,通过自主研发推进药物落地,满足全球未被满足的医疗需求。
斯特赖夫资产管理是一家2022年成立的美国投资管理机构,总部位于俄亥俄州哥伦布市,是斯特赖夫企业股份有限公司旗下子公司。该机构提供共同基金、交易所交易产品以及财富管理服务,是美国证监会注册的投资顾问。
ALGS vs ASST — 直观对比
营收规模更大
ASST
是对方的1.5倍
$169.0K
营收增速更快
ALGS
高出2.0%
-74.1%
两年增速更快
ASST
近两年复合增速
-50.7%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $169.0K | $255.0K |
| 净利润 | — | $-192.3M |
| 毛利率 | — | — |
| 营业利润率 | — | -17288.6% |
| 净利率 | — | -75406.7% |
| 营收同比 | -72.1% | -74.1% |
| 净利润同比 | 75.8% | -2726.9% |
| 每股收益(稀释后) | — | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ALGS
ASST
| Q4 25 | $169.0K | — | ||
| Q3 25 | $741.0K | $255.0K | ||
| Q2 25 | $965.0K | $173.3K | ||
| Q1 25 | $311.0K | $170.7K | ||
| Q4 24 | $606.0K | $212.8K | ||
| Q3 24 | $1.3M | $984.0K | ||
| Q2 24 | $1.1M | $93.0K | ||
| Q1 24 | $694.0K | $124.8K |
净利润
ALGS
ASST
| Q4 25 | — | — | ||
| Q3 25 | $-31.5M | $-192.3M | ||
| Q2 25 | $-15.9M | $-8.9M | ||
| Q1 25 | $43.1M | $-3.7M | ||
| Q4 24 | $-82.2M | $-4.1M | ||
| Q3 24 | $-19.3M | $-6.8M | ||
| Q2 24 | $5.1M | $-5.9M | ||
| Q1 24 | $-34.9M | $-4.8M |
营业利润率
ALGS
ASST
| Q4 25 | — | — | ||
| Q3 25 | -3827.4% | -17288.6% | ||
| Q2 25 | -1924.0% | -1553.9% | ||
| Q1 25 | -6187.5% | -970.5% | ||
| Q4 24 | -3393.2% | -5889.5% | ||
| Q3 24 | -1610.5% | -712.4% | ||
| Q2 24 | -2489.5% | -1857.2% | ||
| Q1 24 | -3176.7% | -1110.9% |
净利率
ALGS
ASST
| Q4 25 | — | — | ||
| Q3 25 | -4256.0% | -75406.7% | ||
| Q2 25 | -1643.8% | -5122.4% | ||
| Q1 25 | 13854.7% | -2195.6% | ||
| Q4 24 | -13556.1% | -1935.5% | ||
| Q3 24 | -1540.7% | -691.3% | ||
| Q2 24 | 477.0% | -6313.1% | ||
| Q1 24 | -5023.5% | -3837.7% |
每股收益(稀释后)
ALGS
ASST
| Q4 25 | — | — | ||
| Q3 25 | $-3.04 | $-0.22 | ||
| Q2 25 | $-1.53 | $-0.17 | ||
| Q1 25 | $-2.11 | $-0.13 | ||
| Q4 24 | $-13.10 | $-5.62 | ||
| Q3 24 | $-3.07 | $-3.06 | ||
| Q2 24 | $0.81 | $-0.58 | ||
| Q1 24 | $-5.58 | $-0.49 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $77.8M | $109.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $53.5M | $779.4M |
| 总资产 | $88.5M | $792.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ALGS
ASST
| Q4 25 | $77.8M | — | ||
| Q3 25 | $99.1M | $109.1M | ||
| Q2 25 | $122.9M | $2.5M | ||
| Q1 25 | $137.9M | $4.2M | ||
| Q4 24 | $56.9M | $6.2M | ||
| Q3 24 | $74.9M | $2.1M | ||
| Q2 24 | $94.5M | $1.9M | ||
| Q1 24 | $112.7M | $1.9M |
股东权益
ALGS
ASST
| Q4 25 | $53.5M | — | ||
| Q3 25 | $71.8M | $779.4M | ||
| Q2 25 | $101.9M | $10.7M | ||
| Q1 25 | $116.4M | $19.6M | ||
| Q4 24 | $-29.0M | $23.3M | ||
| Q3 24 | $50.1M | $27.5M | ||
| Q2 24 | $67.2M | $5.4M | ||
| Q1 24 | $59.8M | $11.3M |
总资产
ALGS
ASST
| Q4 25 | $88.5M | — | ||
| Q3 25 | $109.8M | $792.6M | ||
| Q2 25 | $134.7M | $3.3M | ||
| Q1 25 | $150.7M | $5.0M | ||
| Q4 24 | $70.1M | $28.2M | ||
| Q3 24 | $88.4M | $2.6M | ||
| Q2 24 | $108.8M | $2.4M | ||
| Q1 24 | $127.9M | $2.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-82.5M | $-14.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
ALGS
ASST
| Q4 25 | $-82.5M | — | ||
| Q3 25 | $-24.3M | $-14.0M | ||
| Q2 25 | $-15.5M | $-1.7M | ||
| Q1 25 | $-20.9M | $-1.6M | ||
| Q4 24 | $-18.4M | $-21.6M | ||
| Q3 24 | $-20.1M | $-13.2M | ||
| Q2 24 | $-19.5M | $-1.3M | ||
| Q1 24 | $-22.7M | $-1.0M |
自由现金流
ALGS
ASST
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-21.6M | ||
| Q3 24 | — | $-13.4M | ||
| Q2 24 | — | $-1.3M | ||
| Q1 24 | — | $-1.1M |
自由现金流率
ALGS
ASST
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -10161.2% | ||
| Q3 24 | — | -1360.3% | ||
| Q2 24 | — | -1379.4% | ||
| Q1 24 | — | -844.7% |
资本支出强度
ALGS
ASST
| Q4 25 | — | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 11.3% | ||
| Q3 24 | — | 18.8% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 9.5% |
现金转化率
ALGS
ASST
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.49× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -3.85× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图